New oncogene gives valuable insight into hepatocellular tumors in humans

April 23, 2009

The first identification of GP130 somatic activating mutations* in human tumours was announced today at EASL 2009, the Annual Meeting of the European Association for the Study of Liver Disease in Copenhagen, Denmark.

Identification of recurrent somatic mutation activating GP130 in inflammatory hepatocellular tumours reveals a new pathway of tumourigenesis in humans, according to researchers. This finding reinforces the role of inflammation in hepatocarcinogenesis and particularly in the malignant transformation of hepatocellular adenomas (HCA). Moreover, GP130 mutations will enable the refinement of the molecular classification of hepatocellular tumors in humans.

Inflammatory hepatocellular adenomas (IHCA) are benign liver tumours defined by the presence of inflammatory infiltrates and by an over-expression of inflammatory proteins. IHCA are usually developed in women and their occurrence is frequently associated with obesity and alcohol intake. Recently, somatic mutations were identified that activated GP130 in 60% of IHCA (Rebouissou et al, Nature, 2009), thus defining GP130 as a new oncogene in human tumours. This study aimed to evaluate frequency of GP130 mutations in a wide series of tumours.

Dr Jessica Zucman-Rossi of Inserm U674, Paris, France, who led the study, said: "This exciting advance means we now have a novel means of further investigating the development pathway of hepatocellular tumours as well as a new tool in the classification of hepatocellular tumours. It is an important step forward in our understanding of hepatocarcinogenesis and the future management of this disease."

Researchers in this study screened a series of 400 well-characterised hepatocellular tumours including hepatocellular adenomas, carcinomas, hepatocholangio-carcinoma, fibrolamellar carcinomas and intra-hepatic cholangiocarcinomas. 100 tumours from different organs were also collected. To search for mutations, GP130 exons were screened in all samples and the function of 7 different mutants was analysed in HEP3B.

A somatic mutation was identified in 65% of the IHCA including 24 different small in-frame deletions or duplications. A spectrum of mutations shows that mutations clearly target the IL-6 binding site in GP130. Also demonstrated was the fact that the expression of the most frequent GP130 mutants in HEP3B cells activates STAT3 in absence of IL-6. The researchers searched for possible interaction and cooperation of GP130 activation with other pathways altered in hepatocellular adenoma. HNF1α inactivation and gp130 activation were mutually exclusive in HCA (P< 10-4). By contrast, in half of the ß-catenin activating HCA, a GP130-activating mutation was identified. For two IHCA associated with a malignant transformation, both an activating gp130 and ß-catenin mutations were found. Further, analysis of 220 hepatocellular carcinomas revealed rare GP130 alterations in all cases accompanied by ß-catenin-activating mutations, suggesting a cooperative effect of these signalling pathways in the malignant transformation of hepatocytes.

European Association for the Study of the Liver

---

---

	In vivo anti-tumour activity of corilagin on Hep3B hepatocellular carcinoma.(Short communication)(Report): An article from: Phytomedicine: International Journal of Phytotherapy & Phytopharmacology by Desmond Kwok-Po Hau (Author), Guo-Yuan Zhu (Author), Alexander Kai-Man Leung (Author), Raymond Siu-Ming Wong (Author), Gregory Yin-Ming Cheng (Author), Paul Bo-San Lai (Author), Sze-Wai Tong (Author), Fung-Yi Lau (Author), Kit-Wah Chan (Author), Wai-Yeung Wong (Author), Kim-Hung Lam (Author), Chor-Hing Cheng (Author), Filly Cheung (Author), Chung-Hin Chui (Author), Roberto Gambari (Author), David Wang-Fun Fong (Author) This digital document is an article from Phytomedicine: International Journal of Phytotherapy & Phytopharmacology, published by Urban & Fischer Verlag on December 15, 2010. The length of the article is 2579 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: In vivo anti-tumour activity of corilagin on Hep3B hepatocellular carcinoma.(Short communication)(Report) Author: Desmond Kwok-Po Hau Publication: Phytomedicine: International Journal of Phytotherapy & Phytopharmacology (Magazine/Journal) Date: December 15, 2010 Publisher: Urban & Fischer Verlag Volume: 18 Issue: 1 Page: 11(5) Article...
	Hepatocellular Carcinoma:: Targeted Therapy and Multidisciplinary Care by Kelly M. McMasters (Editor) Hepatocellular Carcinoma: Targeted Therapy provides a detailed repository of the latest information regarding HCC epidemiology, diagnosis, imaging, pathology, staging, and treatment options. This volume also provides an up-to-date guide for treatment that explores not only traditional treatments, but newer investigational treatment options including, surgical resection, liver transplantation, ablation (radiofrequency, microwave), percutaneous ethanol or acetic acid injection, transarterial chemoembolization (TACE), intra-arterial radiation therapy, and systemic chemotherapy. Heptocellular Carcinoma: Targeted Therapy will be of great value to all health care professionals and trainees worldwide who have an interest in the diagnosis and treatment of HCC, including surgeons, medical...
	Hepatocellular Carcinoma: Diagnosis and Treatment (Current Clinical Oncology) by Brian I. Carr (Editor) Hepatocellular cancer is the fifth most common cancer, with 600,000 new cases reported each year worldwide. Additionally, exciting changes in the science of HCC in the last four years have turned the practice of diagnosing and treating the disease upside down. In Hepatocellular Carcinoma: Diagnosis and Treatment, Second Edition, the leading experts in the field of HCC thoroughly update and expand upon the critically acclaimed first edition with all the latest developments in the diagnosis and treatment of primary liver cancer. The book details for physicians the diagnostic and therapeutic decision making process for dealing with such problems as incidental tumors in the liver transplant, the role of neo-adjuvant chemotherapy, intra-arterial vs intravenous therapy, the uses of...
	Malignant Liver Tumours: Basic Concepts and Clinical Management (Falk Symposium) by F. Berr (Editor), J. Bruix (Editor), J. Hauss (Editor), Ch. Wittekind (Editor), J. Wands (Editor) Hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC), both increasing in incidence, have become a major topic of basic and clinical research as well as clinical practice in hepatology. Experts in the field update the current concepts on the carcinogenesis of HCC and CC such as genetic alterations in the pathways of cell cylce and apoptosis regulation, the hypothesis of dedifferentiation of hepatocytes to the malignant phenotype vs that of activation of hepatic progenitor cells incapable of maturation (maturation arrest hypothesis). In spite of an increasing number of genetic alterations described in human HCC as well as cell regulatory pathways tested in experimental HCC models, the key hits causing progression of the cell cycle in imbalance with apoptosis, tissue invasive growth...
	Focal Liver Lesions: Detection, Characterization, Ablation (Medical Radiology / Diagnostic Imaging) by Riccardo Lencioni (Editor), Dania Cioni (Editor), Carlo Bartolozzi (Editor), A.L. Baert (Editor) Few fields of medicine have witnessed such impressive progress as the diagnosis and treatment of liver tumors. Advances in imaging technology, the development of novel contrast agents, and the introduction of optimized scanning protocols have greatly facilitated the non-invasive detection and characterization of focal liver lesions. Furthermore, image-guided techniques for percutaneous tumor ablation have become an accepted alternative treatment for patients with inoperable liver cancer. This book provides a comprehensive and up-to-date overview of the role of diagnostic and interventional radiology in respect of liver tumors. The volume moves from background sections on methodology and segmental liver anatomy to the main sections on the diagnosis of benign and malignant liver lesions. An...
	Clinical Dilemmas in Primary Liver Cancer (Clinical Dilemmas (UK)) by Roger Williams (Editor), Simon D. Taylor-Robinson (Editor) Clinical Dilemmas in Liver Cancer follows the successful format of the other books in the Clinical Dilemmas series, with each chapter focused on a specific dilemma, or issue facing doctors in their day-to-day job, and providing them with practical clinical information and help to better assessment and treat their patients – in this case patients suffering from liver cancer, the third commonest cancer in terms of mortality worldwide.Chapters feature up-to-date information on the basic mechanisms, epidemiological risk factors, screening and surveillance strategies, diagnosis and treatment. It is an extremely practical and clinically-orientated book, and as most patients around the world present with advanced disease, a main focus is on the most recent advances allowing early diagnosis...
	Scheuer's Liver Biopsy Interpretation 9e: Expert Consult: Online and Print, 8e by Jay H. Lefkowitch MD (Author) For over 40 years Scheuer's Liver Biopsy Interpretation has been an invaluable resource for the pathologist in practice and in training in helping to solve diagnostic problems at the microscope. Lavishly illustrated in full color throughout it covers all aspects of liver pathology from the normal, the hepatidities, childhood disease and neoplasms. Copious technical tips and diagnostic 'pearls' reflect the extensive experience and insight of the late Peter Scheuer and Jay Lefkowitch.. Throughout the text histopathologic features are correlated with clinical features to provide a practical account of how pathology impacts the diagnosis and management of liver disease.Well written, complete and concise quick reference.Helps the practicing and trainee pathologist solve diagnostic problems at...
	Diagnostic Immunohistochemistry: Theranostic and Genomic Applications, Expert Consult: Online and Print, 3e by David J. Dabbs MD (Author) Diagnostic Immunohistochemistry presents the latest information and most reliable guidance on immunohistological diagnoses in surgical pathology. David J. Dabbs, MD and other leading experts bring you state-of-the-art coverage on genomic and theranostic applications, molecular anatomic pathology, immunocytology, Non-Hodgkin's lymphoma, and more. Additional features such as tables discussing antibody specifications, differential diagnosis boxes, ancillary anatomic molecular diagnostics, and full-color histological images ensure user-friendly coverage that makes key information easy to find and apply. The fully searchable text is also available online at expertconsult.com, along with a downloadable image bank and access to Path Consult. This concise and complete resource is today's...
	Sherlock's Diseases of the Liver and Biliary System (Sherlock Diseases of the Liver) by James S. Dooley (Editor), Anna Lok (Editor), Andrew Burroughs (Editor), Jenny Heathcote (Editor) Following a Tradition of Excellence from reviews of previous editions:“the best source of synthesized clinical wisdom” – Gastroenterology“a tour de force in terms of knowledge and effort” –The New England Journal of Medicine“the foremost liver book in the world” - The Journal of the American Medical Association“beautifully produced” - HepatologyOver the past 56 years, thousands of physicians have depended on Diseases of the Liver and Biliary System. Its didactic and reliable clinical guidance was - and still is - beyond comparison.This brand-new edition, now named Sherlock's Diseases of the Liver and Biliary System, after the late Professor Dame Sheila Sherlock, continues to provide concise clinical guidance for all those treating patients with hepato-biliary...
	MacSween's Pathology of the Liver: Expert Consult: Online and Print, 6e (Expert Consult Title: Online + Print) by Alastair D. Burt BSc MD FRCPath FlBiol (Editor), Bernard C. Portmann MD FRCPath (Editor), Linda D. Ferrell MD (Editor) MacSween's Pathology of the Liver delivers the expert know-how you need to diagnose all forms of liver pathology using the latest methods. Updated with all the most current knowledge and techniques, this medical reference book will help you more effectively evaluate and interpret both the difficult and routine cases you see in practice.Compare the specimens you encounter in practice to thousands of high-quality images that capture the appearance of every type of liver disease. Efficiently review all the key diagnostic criteria and differential diagnoses for each lesion. Increase understanding of new advances in liver pathology utilizing the most up-to-date information with MacSween's comprehensive reference!